Cargando…
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385467/ https://www.ncbi.nlm.nih.gov/pubmed/34285099 http://dx.doi.org/10.2337/dc21-0904 |
| _version_ | 1783742098947702784 |
|---|---|
| author | Foer, Dinah Cahill, Katherine N. |
| author_facet | Foer, Dinah Cahill, Katherine N. |
| author_sort | Foer, Dinah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8385467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83854672021-09-09 Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 Foer, Dinah Cahill, Katherine N. Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2021-08 2021-08-11 /pmc/articles/PMC8385467/ /pubmed/34285099 http://dx.doi.org/10.2337/dc21-0904 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Comments and Responses Foer, Dinah Cahill, Katherine N. Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title | Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title_full | Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title_fullStr | Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title_full_unstemmed | Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title_short | Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344–1352 |
| title_sort | comment on albogami et al. glucagon-like peptide 1 receptor agonists and chronic lower respiratory disease exacerbations among patients with type 2 diabetes. diabetes care 2021;44:1344–1352 |
| topic | e-Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385467/ https://www.ncbi.nlm.nih.gov/pubmed/34285099 http://dx.doi.org/10.2337/dc21-0904 |
| work_keys_str_mv | AT foerdinah commentonalbogamietalglucagonlikepeptide1receptoragonistsandchroniclowerrespiratorydiseaseexacerbationsamongpatientswithtype2diabetesdiabetescare20214413441352 AT cahillkatherinen commentonalbogamietalglucagonlikepeptide1receptoragonistsandchroniclowerrespiratorydiseaseexacerbationsamongpatientswithtype2diabetesdiabetescare20214413441352 |